Copper Lake Commences Drilling to Depth on High-Grade Copper-Zinc-Silver-Gold Marshall Lake Project
TORONTO, Sept. 29, 2020 (GLOBE NEWSWIRE) — Copper Lake Resources Ltd. (TSX-V: CPL, Frankfurt: W0I) (“Copper Lake” or the “Company”) […]
SWM Increases Production of Alphastar(TM) Electrostatic Air Filtration Media
Alpharetta, GA, Sept. 29, 2020 (GLOBE NEWSWIRE) — In response to customer demand that has more than doubled over the […]
Neuronetics® Celebrates 500,000 Treatment Milestone for Greenbrook® TMS
MALVERN, Pa., Sept. 29, 2020 (GLOBE NEWSWIRE) — Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, […]
BioCardia Issued New Patent for Delivery of Cardiac Cell Therapy Through Wrist Artery
SAN CARLOS, Calif., Sept. 29, 2020 (GLOBE NEWSWIRE) — BioCardia®, Inc. [Nasdaq: BCDA] a leader in the development of comprehensive solutions […]
Aprea Therapeutics Appoints Michael A. Kelly to Board of Directors
BOSTON, Sept. 29, 2020 (GLOBE NEWSWIRE) — Aprea Therapeutics Inc., (NASDAQ: APRE), a clinical-stage biotechnology company focused on developing and […]
Cerence and PATEO Bring Conversational AI to Indonesia’s First Connected Car from SAIC-GM-Wuling
BURLINGTON, Mass., Sept. 29, 2020 (GLOBE NEWSWIRE) — Cerence Inc. (NASDAQ: CRNC), AI for a world in motion, today announced […]
VBL Therapeutics to Present at the Chardan 4th Annual Genetic Medicines Conference
TEL AVIV, Israel, Sept. 29, 2020 (GLOBE NEWSWIRE) — VBL Therapeutics (Nasdaq: VBLT), a clinical-stage biotechnology company focused on the […]
R1 Increases Footprint in Hospital-Based Physician Market with Addition of Prominent Emergency Physician Groups
CHICAGO, Sept. 29, 2020 (GLOBE NEWSWIRE) — R1 RCM Inc. (NASDAQ:RCM), a leading provider of technology-enabled revenue cycle management services to […]
First Merchants President & CEO Michael C. Rechin announces retirement
MUNCIE, Ind., Sept. 29, 2020 (GLOBE NEWSWIRE) — After more than 13 years of leading significant growth and success for […]
LifeSci Acquisition Corp. Announces Merger Agreement with Vincera Pharma, Inc. to Create New Publicly Listed Oncology Company
Vincera is expected to have approximately $60 million at closing to fund clinical and preclinical development pipelineStockholders of Vincera post-closing […]
